Susvimo has the same active ingredient as Roche's big-selling therapy Lucentis (ranibizumab), a VEGF inhibitor administered once a month that has been approved by the FDA since 2006 for wet AMD.

SOUTH SAN FRANCISCO, Calif., April 03, 2025--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that new data were presented at the AD/PD 2025 International ...

Analysts at GlobalData think that faricimab and another Roche-developed product will be the main derivers of the market in the coming years. The companion product – Susvimo – is an implantable ...

Roche Holdings AG (OTC:RHHBY) on Friday announced new 96-week data for fenebrutinib demonstrating that patients with relapsing multiple sclerosis (RMS) maintained no disability progression and low ...

June 02, 2025--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today positive results from the Phase III IMforte study of Tecentriq® (atezolizumab) in combination ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Hovanesian: Coordinated care is what we do every day. We have fabulous optometrists who really function like non-surgical ophthalmologists and ophthalmologists who increasingly are focusing their ...

Telemedicine helped increase access to endocrinology care for adults with type 2 diabetes and atherosclerotic cardiovascular disease living in rural areas, but several disparities remain ...

Roche has decided to stop producing the branded version of a drug prescribed to millions who became overwhelmed by the stress of living in the 20th century. Valium was dubbed the ' housewives ...

Roche’s Susvimo approved by FDA for diabetic retinopathy SA News Thu, May 22 ... Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin ...